Search
Now showing items 41-50 of 116
Diabetes. Segunda edición
(2010)
Thalidomide and its analogs: a potential immunomodulatory alternative for treating liver diseases and cirrhosis
(2011)
Thalidomide is currently used for treating erythema nodosum leprosum, multiple myeloma, angiogenesis, rheumatoid arthritis, graft-versus-host disease, among others. Thalidomide effects are related to its capacity to inhibit ...
Antigenotoxic Studies of Different Substances to Reduce the DNA damage Induced by Aflatoxin B1 and Ochratoxin A
(2010)
Mycotoxins are produced mainly by the mycelial structure of filamentous fungi,or more specifically, molds. These secondary metabolites are synthesized during the end ofthe exponential growth phase and appear to have no ...
Inflammation, Oxidative Stress, and Obesity
(2011)
Obesity is a chronic disease of multifactorial origin and can be defined as an increase in the accumulation of body fat. Adipose tissue is not only a triglyceride storage organ, but studies have shown the role of white ...
Antinociceptive, genotoxic and histopathological study of Heliopsis longipes S.F. Blake in mice
(2010)
Ethnopharmacological relevance: H. longipes S.F. Blake (Asteraceae) is a Mexican plant, whose roots aretraditionally used as a condiment, as a mouth anesthetic, and as an antiparasitic. Affinin is the alkamidepresent in ...
Exposure to Sodium Fluoride Produces Signs of Apoptosis in Rat Leukocytes
(2010)
Fluoride is naturally present in the earth's crust and can be found in rocks, coal, and clay; thus, it can be found in small quantities in water, air, plants, and animals. Therefore, humans are exposed to fluoride through ...
In vivo extracellular matrix protein expression by human periodontal ligament after stimulation with orthodontic force
(2010)
It is well known that the orthodontic force applied to teeth generates a series of events that remodel theperiodontal ligament (PDL). Extracellular matrix proteins (ECM) are described as molecular regulatorsof these events. ...
Pharmacokinetic pharmacodynamic modelling of the analgesic effects of lumiracoxib, a selective inhibitor of cyclooxygenase-2, in ratsbph
(2010)
This study establishes a pharmacokinetic/pharmacodynamic (PK/PD) model to describe the time course and in vivo mechanisms of action of the antinociceptive effects of lumiracoxib, evaluated by the thermal hyperalgesia test in rats.